Dual blockade of the renin-angiotensin system in diabetic nephropathy

被引：9

作者：

Cooper, M ^{[1
]}

Boner, G ^{[1
]}

机构：

[1] Baker Med Res Inst, Melbourne, Vic, Australia

来源：

DIABETIC MEDICINE | 2004年 / 21卷

关键词：

D O I：

10.1111/j.1466-5468.2004.1180g.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：15 / 18

页数：4

共 27 条

[1] Long-term renoprotective effects of losartan in diabetic nephropathy [J].

Andersen, S ;

Tarnow, L ;

Cambien, F ;

Rossing, P ;

Juhl, TR ;

Deinum, J ;

Parving, HH .

DIABETES CARE, 2003, 26 (05) :1501-1506

[2] Optimal dose of losartan for renoprotection in diabetic nephropathy [J].

Andersen, S ;

Rossing, P ;

Juhl, TR ;

Deinum, J ;

Parving, HH .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (08) :1413-1418

[3] Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].

Bakris, GL ;

Williams, M ;

Dworkin, L ;

Elliott, WJ ;

Epstein, M ;

Toto, R ;

Tuttle, K ;

Douglas, J ;

Hsueh, W ;

Sowers, J .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661

[4]

Boner Geoffrey, 2002, Diabetes Technol Ther, V4, P313, DOI 10.1089/152091502760098456

[5] Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors [J].

Brenner, BM ;

Zagrobelny, J .

KIDNEY INTERNATIONAL, 2003, 63 :77-85

[6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[7] Identification and management of diabetic nephropathy in the diabetes clinic [J].

Craig, KJ ;

Donovan, K ;

Munnery, M ;

Owens, DR ;

Williams, JD ;

Phillips, AO .

DIABETES CARE, 2003, 26 (06) :1806-1811

[8] SODIUM RESTRICTION AND BLOOD-PRESSURE IN HYPERTENSIVE TYPE-II DIABETICS - RANDOMIZED BLIND CONTROLLED AND CROSSOVER STUDIES OF MODERATE SODIUM RESTRICTION AND SODIUM SUPPLEMENTATION [J].

DODSON, PM ;

BEEVERS, M ;

HALLWORTH, R ;

WEBBERLEY, MJ ;

FLETCHER, RF ;

TAYLOR, KG .

BMJ-BRITISH MEDICAL JOURNAL, 1989, 298 (6668) :227-230

[9] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].

Eknoyan, G ;

Levin, NW .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266

[10] Aldosterone receptor blockade and the role of eplerenone: evolving perspectives [J].

Epstein, M .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :1984-1992

← 1 2 3 →